Estrogen-progestin replacement and risk of breast cancer
Glaser, A.N.
JAMA 284(6): 692; Author Reply 693-4
2000
ISSN/ISBN: 0098-7484 PMID: 10927767 Document Number: 522920
Document emailed within 1 workday
Related Documents
Persson, I. 1996: Cancer risk in women receiving estrogen-progestin replacement therapy Maturitas 23(Suppl): S37-S45Nachtigall, M.J.; Smilen, S.W.; Nachtigall, R.D.; Nachtigall, R.H.; Nachtigall, L.E. 1992: Incidence of breast cancer in a 22-year study of women receiving estrogen-progestin replacement therapy Obstetrics and Gynecology 80(5): 827-830
Stephens, M.B. 2000: Estrogen-progestin increases breast cancer risk Journal of Family Practice 49(4): 301-302
Chlebowski, R.T.; Rohan, T.E.; Manson, J.E.; Aragaki, A.K.; Kaunitz, A.; Stefanick, M.L.; Simon, M.S.; Johnson, K.C.; Wactawski-Wende, J.; O'Sullivan, M.J.; Adams-Campbell, L.L.; Nassir, R.; Lessin, L.S.; Prentice, R.L. 2015: Breast Cancer After use of Estrogen Plus Progestin and Estrogen Alone: Analyses of Data from 2 Women's Health Initiative Randomized Clinical Trials JAMA Oncology 1(3): 296-305
Santen, R.J.; Pinkerton, J.; McCartney, C.; Petroni, G.R. 2001: Risk of breast cancer with progestins in combination with estrogen as hormone replacement therapy Journal of Clinical Endocrinology and Metabolism 86(1): 16-23
2002: New SBU-report on estrogen replacement therapy in climacteric. Moderate risk of breast cancer after long-term use Lakartidningen 99(28-29): 3031-3034
Schildkraut, J.M.; Calingaert, B.; Marchbanks, P.A.; Moorman, P.G.; Rodriguez, G.C. 2002: Impact of progestin and estrogen potency in oral contraceptives on ovarian cancer risk Journal of the National Cancer Institute 94(1): 32-38
Grant, E.C.G. 2017: Lifetime cancer risk with progestin and estrogen oral contraceptives and hormone therapy American Journal of Obstetrics and Gynecology 217(2): 232-233
Faber, M.T.; Jensen, A.; Frederiksen, K.; Glud, E.; Høgdall, E.; Høgdall, C.; Blaakaer, J.; Kjaer, S.K. 2013: Oral contraceptive use and impact of cumulative intake of estrogen and progestin on risk of ovarian cancer Cancer Causes and Control: Ccc 24(12): 2197-2206
Zahl, P-Henrik.; Maehlen, J. 2005: Estrogen replacement therapy and breast cancer Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 125(8): 1045; Author Reply 1045
Brewster, W.R.; DiSaia, P.J.; Grosen, E.A.; McGonigle, K.F.; Kuykendall, J.L.; Creasman, W.T. 1999: An experience with estrogen replacement therapy in breast cancer survivors International Journal of Fertility and Women's Medicine 44(4): 186-192
Horwitz, K.B. 1985: The antiprogestin RU38 486: receptor-mediated progestin versus antiprogestin actions screened in estrogen-insensitive T47Dco human breast cancer cells Endocrinology 116(6): 2236-2245
Spicer, D.; Pike, M.C.; Henderson, B.E. 1990: The question of estrogen replacement therapy in patients with a prior diagnosis of breast cancer Oncology 4(12): 49-54 59; Discussion 59 62
Xing, S.; Wu, Y.; Liu, J.; Xu, R.; Zhang, Z.; Wang, Y. 2003: A comparison of two different dosages of conjugated equine estrogen in continuous combined hormone replacement therapy with progestin Chinese Medical Journal 116(4): 584-587
Calle, E.E.; Miracle-McMahill, H.L.; Thun, M.J.; Heath, C.W. 1995: Estrogen replacement therapy and risk of fatal colon cancer in a prospective cohort of postmenopausal women Journal of the National Cancer Institute 87(7): 517-523
Hlatky, M.A.; Boothroyd, D.; Vittinghoff, E.; Sharp, P.; Whooley, M.A. 2002: Quality-of-life and depressive symptoms in postmenopausal women after receiving hormone therapy: results from the Heart and Estrogen/Progestin Replacement Study (HERS) trial JAMA 287(5): 591-597
Corenblum, B.; Donovan, L. 1993: The safety of physiological estrogen plus progestin replacement therapy and with oral contraceptive therapy in women with pathological hyperprolactinemia Fertility and Sterility 59(3): 671-673
Dargent, D. 2000: Estrogen replacement therapy in patients in remission after treatment for estrogen dependent cancer. Certainties are still lacking Gynecologie Obstetrique and Fertilite 28(6): 427-428
Schlesselman, J.J.; Stadel, B.V.; Murray, P.; Lai, S.H. 1987: Breast cancer risk in relation to type of estrogen contained in oral contraceptives Contraception 36(6): 595-613
Porcelli, A.; Calleri, L.; Gallello, D.; Taccani, C.; Surico, N. 1997: Estrogen-progestin contraception and biohumoral response of new markers of the atheroma risk. Behavior of lipoprotein(a) and apolipoproteins a and B Minerva Ginecologica 49(3): 63-66